Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation

Journal of Investigative Dermatology

Volumn 131, Issue 4, 2011, Pages 925-931

  Yoshihisa, Yoko ^a   Makino, Teruhiko ^a   Matsunaga, Kenji ^a   Honda, Ayumi ^b   Norisugi, Osamu ^a   Abe, Riichiro ^b   Shimizu, Hiroshi ^b   Shimizu, Tadamichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOTAXIN; INTERLEUKIN 5; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FIBROBLAST; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATCH TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ALLERGY; SKIN SENSITIZATION; TRANSGENIC MOUSE; WILD TYPE;

EID: 79952765250     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.418     Document Type: Article

References (50)

1. Akagi Y, Isaka Y, Akagi A et al. (1997) Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and beta-actin/beta-globin gene in glomerular epithelial cells in vivo. Kidney Int 51:1265-9 (Pubitemid 27186555)
2. Bernhagen J, Calandra T, Bucala R (1998) Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med 76:151-61 (Pubitemid 28098701)
3. Bernhagen J, Calandra T, Mitchell RA et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-9 (Pubitemid 23339882)
4. Bloom BR, Bennett B (1966) Mechanism of reaction in vivo associated with delayed-type hypersensitivity. Science 153:80-2
5. Bucala R (1996) MIF re-evaluated: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 7:19-24 (Pubitemid 27202662)
6. Cheng Q, McKeown SJ, Santos L et al. (2010) Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J Immunol 185:1238-47
7. Donnelly SC, Haslett C, Reid PT et al. (1997) Regulatory role for macrophage migration Inhibitory factor in acute respiratory distress syndrome. Nat Med 3:320-3 (Pubitemid 27112930)
8. Fujisawa T, Kato Y, Atsuta J et al. (2000) Chemokine production by the BEAS-2B human bronchial epithelial cells: differential regulation of eotaxin, IL-8, and RANTES by TH2- and TH1-derived cytokines. J Allergy Clin Immunol 105:126-33 (Pubitemid 30059112)
9. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT et al. (1996) Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 2:449-56 (Pubitemid 26193013)
10. Gregory JL, Leech MT, David JR et al. (2004) Reduced leukocyte- endothelial cell interactions in the inflamed microcirculation of macrophage migration inhibitory factor-deficient mice. Arthritis Rheum 50:3023-34 (Pubitemid 39209542)
11. Gregory JL, Morand EF, McKeown SJ et al. (2006) Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol 177:8072-9 (Pubitemid 44846325)
12. Hamasaka A, Abe R, Koyama Y et al. (2009) DNA vaccination against macrophage migration inhibitory factor improves atopic dermatitis in murine models. J Allergy Clin Immunol 124:90-9
13. Honma N, Koseki H, Akasaka T et al. (2000) Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotox-aemia. Immunology 100:84-90 (Pubitemid 30242886)
14. Jose PJ, Griffiths-Johnson DA, Collins PD et al. (1994) Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 179:881-7 (Pubitemid 24065646)
15. Kapp A (1995) Atopic dermatitis-the skin manifestation of atopy. Clin Exp Allergy 25:210-9
16. Kleemann R, Hausser A, Geiger R et al. (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-6
17. Lampinen M, Carlson M, Hakansson LD et al. (2004) Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59:793-805 (Pubitemid 39005818)
18. Leiferman KM (1989) Eosinophils in atopic dermatitis. Allergy 44:20-6 (Pubitemid 19225812)
19. Leng L, Metz CN, Fang Y et al. (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467-76 (Pubitemid 36686708)
20. Leung DY, Nicklas RA, Li JT et al. (2004) Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 93:S1-21
21. Li L, Xia Y, Nguyen A et al. (1999) Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 162:2477-87 (Pubitemid 29309264)
22. Lue H, Dewor M, Leng L et al. (2011) Activation of the JNK signaling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74. Cell Signal 23:135-44
23. Magalhães ES, Mourao-Sa DS, Vieira-de-Abreu A et al. (2007) Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation. Eur J Immunol 37:1097-106
24. Magalhães ES, Paiva CN, Souza HS et al. (2009) Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infecton. FASEB J 23:1262-71
25. Mizue Y, Ghani S, Leng L et al. (2005) Role for macrophage migration inhibitory factor in asthma. Proc Natl Acad Sci USA 102:14410-5 (Pubitemid 41429711)
26. Mochizuki M, Bartels J, Mallet AI et al. (1998) IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 160:60-8 (Pubitemid 28116715)
27. Morar N, Willis-Owen SA, Moffatt MF et al. (2006) The genetics of atopic dermatitis. J Allergy Clin Immunol 118:24-34 (Pubitemid 43946476)
28. Nakamaru Y, Oridate N, Nishihira J et al. (2005) Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis. Cytokine 31:103-8 (Pubitemid 40910225)
29. Nakamura H, Haley KJ, Nakamura T et al. (1998) Differential regulation of eotaxin expression by TNF-alpha and PMA in human monocytic U-937 cells. Am J Physiol 275:L601-10
30. Ponath PD, Qin S, Post TW et al. (1996) Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 183:2437-48 (Pubitemid 26192353)
31. Roger T, David J, Glauser MP et al. (2001) MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920-4 (Pubitemid 34024744)
32. Rossi AG, Haslett C, Hirani N et al. (1998) Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF): potential role in asthma. J Clin Invest 15:2869-74 (Pubitemid 28294596)
33. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101-9
34. Sasaki S, Nishihira J, Ishibashi T et al. (2004) Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney. Kidney Int 65:469-81 (Pubitemid 38130641)
35. Shimizu T (2005) Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci 37:65-73 (Pubitemid 40126824)
36. Shimizu T, Abe R, Ohkawara A et al. (1997) Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophy Res Commun 240:173-8 (Pubitemid 27503770)
37. Shimizu T, Abe R, Ohkawara A et al. (1999) Increased production of macrophage migration inhibitory factor (MIF) by PBMCs of atopic dermatitis. J Allergy Clin Immunol 104:659-64 (Pubitemid 29451660)
38. Shimizu T, Nishihira J, Watanabe H et al. (2004) Cetirizine, an H1-receptor antagonist, suppresses the expression of macrophage migration inhibitory factor (MIF): its potential anti-inflammatory action. Clin Exp Allergy 34:103-9 (Pubitemid 38183687)
39. Shimizu T, Ohkawara A, Nishihira J et al. (1996) Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohisto-chemical localization. FEBS Lett 381:188-202
40. Spergel JM, Mizoguchi E, Brewer JP et al. (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperre-sponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101:1614-22 (Pubitemid 28198490)
41. Spergel JM, Mizoguchi E, Oettgen H et al. (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103:1103-11 (Pubitemid 29207243)
42. Stellato C, Matsukura S, Fal A et al. (1999) Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and glucocorticoid budeso-nide. J Immunol 163:5624-32
43. Terada N, Hamano N, Nomura T et al. (2000) Interleukin-13 and tumor necrosis factor-a synergistically induce eotaxin production in human nasal fibroblasts. Clin Exp Allergy 20:348-55 (Pubitemid 30167250)
44. Uguccioni M, Loetscher P, Forssmann U et al. (1996) Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 183:2379-84 (Pubitemid 26158931)
45. Wang B, Huang X, Wolters PJ et al. (2006) Cutting edge: deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses. J Immunol 177:5779-84 (Pubitemid 44628790)
46. Wang B, Zhang Z, Wang Y et al. (2009) Molecular cloning and characterization of macrophage migration inhibitory factor from small abalone Haliotis diversicolor supertexta. Fish Shellfish Immunol 27:57-64
47. Weiser WY, Temple PA, Witek-Giannotti JS et al. (1989) Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 86:7522-6 (Pubitemid 19254488)
48. Yamaguchi E, Nishihira J, Shimizu T et al. (2000) Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy 30:1244-9
49. Yawalkar N, Uguccioni M, Schärer J et al. (1999) Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J invest Dermatol 113:43-8 (Pubitemid 29328157)
50. Ying S, Robinson DS, Meng Q et al. (1997) Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic athma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 27:3507-16 (Pubitemid 28018050)